Provided by Tiger Trade Technology Pte. Ltd.

Protalix BioTherapeutics

2.07
-0.0600-2.82%
Post-market: 2.07-0.0003-0.01%18:11 EDT
Volume:729.10K
Turnover:1.51M
Market Cap:166.47M
PE:-25.25
High:2.14
Open:2.13
Low:2.03
Close:2.13
52wk High:3.19
52wk Low:1.32
Shares:80.42M
Float Shares:60.76M
Volume Ratio:0.46
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0820
EPS(LYR):-0.0841
ROE:-14.44%
ROA:-4.41%
PB:3.45
PE(LYR):-24.62

Loading ...

Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 08, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Jun 01, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 01, 2020

Major Issues Report

8-K - Current report
May 28, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Major Issues Report

Current report, items 8.01 and 9.01
May 11, 2020

Major Issues Report

Current report, item 8.01
Apr 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 30, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 25, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 23, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 18, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 12, 2020

Major Issues Report

Current report, items 1.01, 3.02, 8.01, and 9.01
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals